findmyKOL

David Clifford, MD

Enriched profile

Melba and Forest Seay Professor of Clinical Neuropharmacology in Neurology; Professor of Medicine; Section Chief, Section of Neuroinfectious Diseases · Washington University in St. Louis

ORCIDNPI
Region🇺🇸 Saint Louis, MO · Midwest · United StatesSpecialtyNeurologyFocusHIV Research and Treatment+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceverified 2026Payments2021–2025NIH funding1985–2022

David Clifford is Melba and Forest Seay Professor of Clinical Neuropharmacology in Neurology; Professor of Medicine; Section Chief, Section of Neuroinfectious Diseases at Washington University in St. Louis. OpenAlex indexes 350 publications with 28,597 citations (h-index 79); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

David Clifford, MD, is Melba and Forest Seay Professor of Clinical Neuropharmacology in Neurology at Washington University in St. Louis (Washington University School of Medicine, Department of Neurology). The public record shows 350 publications with 28,597 citations (h-index 79), centered on HIV Research and Treatment, HIV-related health complications and treatments, Polyomavirus and related diseases. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 5 companies, 10 NIH-funded awards (1985–2022).

  • Most recent indexed publication: 2025 · Neurology. Clinical practice
  • Top research focus: HIV Research and Treatment
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 5 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
HIV3 trialsHIV Infections2 trials

Research focus

OpenAlex concept fingerprint
HIV Research and TreatmentHIV-related health complications and treatmentsPolyomavirus and related diseasesHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Drugs & molecules

across trials, industry payments and publications
Ocrevusgeneric · OcrelizumabClinical trialsIndustry payments7PublicationsAdcetrisgeneric · Brentuximab vedotinClinical trialsIndustry payments2PublicationsUpliznageneric · InebilizumabClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Sanofi Us Services Inc.Clinical trialsIndustry payments16F. Hoffmann-La Roche AGClinical trialsIndustry payments8Seagen Inc.Clinical trialsIndustry payments4

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
350publications

Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.

28,597citations

Total citations across indexed works.

79h-index

Hirsch index (OpenAlex). i10-index 229.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
5companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
10NIH grants · 1985–2022

Federally funded research awards.

View funding

Public positions

sourced statements on record
  • Member

    NIH Office of AIDS Research Advisory Council (OARAC), appointed 2010

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oar.nih.gov

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    85%
    Fatty acid derivatives23%
    Divalproex Sodium Er58%Divalproex Sodium42%
    Part D<11 patients
    Other antiepileptics20.3%
    Levetiracetam100%
    Part D<11 patients
  • Musculoskeletal

    15%
    gamma-Aminobutyric Acid-ergic Agonist15%
    Baclofen100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

10 NIH research awards on record, funded 19852022 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Ronald J. Ellis78Christina M. Marra75David M. Simpson71

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/david-clifford-md-5c19bba4

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • Doximity

    doximity.com/pub/david-clifford-md-9ae9fef3

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/David-Clifford-6

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    peoplebehindthescience.com/dr-david-clifford

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →peoplebehindthescience.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Residency

    Internal Medicine and Neurology, Washington University/Barnes Hospital Consortium

    1980
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →peoplebehindthescience.com
  • MD

    Washington University School of Medicine

    1975
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu
  • BA

    Southwestern University (Georgetown, TX)

    1971
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southwestern.edu
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com

Editorial & leadership roles

journal and society appointments
  • Founder/Director

    Neurologic AIDS Research Consortium

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu
  • Section Chief

    Section of Neuroinfectious Diseases, Department of Neurology, Washington University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.wustl.edu
  • Principal Investigator

    Washington University AIDS Clinical Trials Unit

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →southwestern.edu
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
3 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
2 more affiliations behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.